ipilimumab,nivolumab
bms
[]
cm-649: 3-yr fu of nivo + chemo as 1l therapy for mgc/gejc/eac. greatest benefit for pd-l1 cps&gt;5 #ascogi23 
Gastrointestinal Medical Oncologist. Professor of Medicine and Attending Physician at University of Nuevo Leon Cancer Center.  🇲🇽